Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 1/20 | 0.63 |
| ▸ | DYRK1A | Q13627 | 4/20 | 0.50 |
| ▸ | DHODH | Q02127 | 3/20 | 0.50 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.50 |
| ▸ | PIM1 | P11309 | 3/20 | 0.46 |
| ▸ | DYRK1B | Q9Y463 | 3/20 | 0.45 |
| ▸ | CLK1 | P49759 | 2/20 | 0.45 |
| ▸ | CDK9 | P50750 | 2/20 | 0.45 |
| ▸ | DYRK2 | Q92630 | 2/20 | 0.45 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.45 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.45 |
| ▸ | CLK2 | P49760 | 1/20 | 0.45 |
| ▸ | GSK3B | P49841 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | RNASEH1 | O60930 | 1/20 | 0.45 |
| ▸ | ERCC1 | P07992 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29849579 | 1.00 | ALDH1A1 (0.63) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL29402079 | 0.85 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL1332157 | 0.85 | MAP2K3 (0.50) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL6783762 | 0.85 | ALDH1A1 (0.59) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL28149300 | 0.83 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL27775101 | 0.83 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL2908831 | 0.83 | ALDH1A1 (0.62) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL5388884 | 0.83 | ALDH1A1 (0.57) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH | |
| SCHEMBL6079236 | 0.82 | HDAC8 (0.48) | ALDH1A1SMN1; SMN2MAPTDHODHPDE10A | |
| SCHEMBL31109172 | 0.82 | SMN1; SMN2 (0.55) | ALDH1A1SMN1; SMN2MAPTDYRK1ADHODH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023246355-A1 | GINKGO LEAF ORGANIC ACID EXTRACT, METHOD FOR PREARING SAME AND USE THEREOF | 浙江康恩贝制药股份有限公司 | 2023-12-28 | — | — | WO | claimed |
| CN-117089040-A | Aqueous polyurethane-urea emulsion modified based on aniline trimer and epoxy resin and preparation method thereof | 西华大学 | 2023-11-21 | — | — | CN | claimed |
| CN-115078588-B | Aspongopus and quality evaluation method of processed product thereof | 江阴天江药业有限公司 | 2023-07-07 | — | — | CN | claimed |
| CN-114624343-B | Method for relatively quantifying 45 inflammations and immune metabolites in serum | 中国科学院大连化学物理研究所 | 2023-01-24 | — | — | CN | claimed |
| CN-115078588-A | Aspongopus and quality evaluation method of processed product thereof | 江阴天江药业有限公司 | 2022-09-20 | — | — | CN | claimed |
| CN-114624343-A | Method for relative quantification of 45 inflammations and immune metabolites in serum | 中国科学院大连化学物理研究所 | 2022-06-14 | — | — | CN | claimed |
| CN-110423283-B | Water-based nitrocotton, emulsion thereof and preparation method thereof | 西华大学 | 2021-09-07 | — | — | CN | claimed |
| CN-110078883-B | Water-based paint resin based on konjac flour, preparation method and composition thereof | 西华大学 | 2021-08-03 | — | — | CN | claimed |
| CN-110437678-B | Energy-saving environment-friendly water-based paint and preparation method thereof | 西华大学 | 2021-04-27 | — | — | CN | claimed |
| CN-110423520-A | A kind of environment-friendly water-based glass coating and preparation method thereof | SICHUAN YIBIN GLOBAL GELASI GLASS MFG CO LTD | 2019-11-08 | — | — | CN | claimed |
| US-20100041756-A1 | METHOD OF MODULATING B CELL FUNCTIONING | IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY & MEDICINE (GB) | 2010-02-18 | — | — | US | claimed |
| EP-1824469-A4 | A METHOD OF MODULATING B CELL FUNCTIONING | NUON THERAPEUTICS PTY LTD (AU) | 2008-07-30 | — | — | EP | claimed |
| CN-101232878-A | Method of modulating T cell functioning | UNIV LELAND STANFORD JUNIOR (US) | 2008-07-30 | — | — | CN | claimed |
| EP-1845967-A4 | A METHOD OF MODULATING T CELL FUNCTIONING | UNIV LELAND STANFORD JUNIOR (US) | 2008-03-05 | — | — | EP | claimed |
| US-20080009519-A1 | METHOD OF MODULATING T CELL FUNCTIONING | ANGIOGEN PHARMACEUTICALS PTY LIMITED (AU) | 2008-01-10 | — | — | US | claimed |
| CN-101098687-A | Methods of modulating B cell function | ANGIOGEN PHARMACEUTICALS PTY L (AU) | 2008-01-02 | — | — | CN | claimed |
| EP-1845967-A2 | A METHOD OF MODULATING T CELL FUNCTIONING | The Board of Trustees of Leland Stanford Junior University (US) | 2007-10-24 | — | — | EP | claimed |
| EP-1824469-A1 | A METHOD OF MODULATING B CELL FUNCTIONING | Angiogen Pharmaceuticals Pty. Ltd (AU) | 2007-08-29 | — | — | EP | claimed |
| WO-2006076580-A2 | A METHOD OF MODULATING T CELL FUNCTIONING | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2006-07-20 | — | — | WO | claimed |
| WO-2006053390-A1 | A METHOD OF MODULATING B CELL FUNCTIONING | ANGIOGEN PHARMACEUTICALS PTY. LTD. (AU) | 2006-05-26 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080009519-A1 | METHOD OF MODULATING T CELL FUNCTIONING | IFNG, CD4, IDO1 | ALDH1A1 1352/4885SMN1; SMN2 4156/4885MAPT 3672/4885 |
| US-20100041756-A1 | METHOD OF MODULATING B CELL FUNCTIONING | KYNU, IDO1, IDO2 | ALDH1A1 1104/4885SMN1; SMN2 4850/4885MAPT 4146/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.